NIH-funded research R01 grant

Understanding how the thymus prevents autoimmune reactions during immune activation

Official title: TCR signaling in thymic selection: Role of innate immune activation

Funded at University of Minnesota · NIH-11126836 · Data updated 2026-11-12

This study is looking at how a part of your immune system called the thymus helps keep your body from attacking itself during times of stress, like when you're healing from an injury or dealing with inflammation, and it’s for anyone interested in understanding how we can prevent autoimmune diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startJuly 1, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$641,069
NIH project number5R01AI179749-02
Project IDNIH-11126836 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with autoimmune conditions or those at risk of developing such disorders.

Less likely to help

Patients with established autoimmune diseases that are not related to T cell tolerance may not benefit from this research.

What this research studies

This research investigates the role of the thymus in maintaining tolerance to self-antigens during immune activation, such as inflammation and wound healing. It aims to understand how type I and III interferons produced by the thymus influence T cell development and tolerance. The study will explore the mechanisms by which these interferons affect the selection of T regulatory cells, which are crucial for preventing autoimmune diseases. By examining these processes, the research seeks to provide insights into how the immune system can function effectively without triggering harmful autoimmune responses.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing autoimmune diseases by enhancing T cell tolerance.

How similar studies have gone: Previous research has shown promising results in understanding T cell tolerance mechanisms, indicating that this approach has potential for success.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Hogquist, Kristin a. — University of Minnesota
  • Study coordinator: Hogquist, Kristin a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.